Joo-Hang Kim Selected Research

Joo-Hang Kim Research Topics

Disease

55	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2005
40	Neoplasms (Cancer) 07/2021 - 11/2002
15	Disease Progression 01/2022 - 03/2010
7	Lung Neoplasms (Lung Cancer) 10/2020 - 08/2005
7	Breast Neoplasms (Breast Cancer) 12/2014 - 07/2003
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 12/2006
6	Neutropenia 01/2020 - 11/2011
5	Adenocarcinoma 12/2016 - 02/2007
4	Febrile Neutropenia 01/2020 - 11/2011
4	Carcinogenesis 06/2015 - 08/2002
3	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2016
3	Melanoma (Melanoma, Malignant) 01/2021 - 10/2014
3	Carcinoma (Carcinomatosis) 12/2020 - 03/2012
3	Hypertension (High Blood Pressure) 01/2020 - 08/2014
3	Fatigue 01/2018 - 11/2013
3	Neoplasm Metastasis (Metastasis) 04/2017 - 10/2006
3	Exanthema (Rash) 01/2017 - 03/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 02/2007
2	Pneumonia (Pneumonitis) 01/2022 - 01/2018
2	Esophageal Neoplasms (Esophageal Cancer) 07/2021 - 04/2014
2	Diarrhea 12/2016 - 12/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2016 - 02/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 04/2015
2	Stomach Neoplasms (Stomach Cancer) 03/2016 - 11/2002
2	Thyroid Neoplasms (Thyroid Cancer) 03/2016 - 08/2015
2	Infections 06/2015 - 10/2006
2	Pain (Aches) 11/2013 - 04/2013
2	Necrosis 05/2013 - 02/2005
1	Gastritis 01/2022
1	Intestinal Perforation 07/2021
1	Colitis 07/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2019

Drug/Important Bio-Agent (IBA)

20	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2007
16	Tyrosine Kinase InhibitorsIBA 07/2021 - 03/2010
15	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 12/2005
14	Docetaxel (Taxotere)FDA Link 01/2020 - 12/2005
12	PlatinumIBA 01/2020 - 05/2007
11	Pemetrexed (MTA)FDA Link 12/2016 - 06/2011
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 03/2010
7	Gefitinib (Iressa)FDA Link 08/2017 - 03/2010
6	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2002
6	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 12/2006
6	Bevacizumab (Avastin)FDA Link 12/2016 - 06/2011
5	RamucirumabIBA 01/2021 - 08/2014
5	Gemcitabine FDA Link 01/2017 - 06/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2011
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
4	osimertinibIBA 01/2021 - 04/2015
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2012
4	Messenger RNA (mRNA)IBA 01/2020 - 07/2003
4	Monoclonal AntibodiesIBA 02/2017 - 11/2007
4	Small Interfering RNA (siRNA)IBA 02/2017 - 02/2007
3	AfatinibIBA 07/2021 - 01/2016
3	NivolumabIBA 07/2021 - 01/2018
3	Interleukin-12 (IL 12)IBA 01/2021 - 10/2006
3	durvalumabIBA 12/2020 - 01/2018
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 12/2006
3	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 12/2005
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 12/2009
3	Tumor Biomarkers (Tumor Markers)IBA 03/2016 - 08/2011
3	Formaldehyde (Formol)FDA Link 03/2016 - 01/2015
3	ParaffinIBA 03/2016 - 01/2015
3	adenovirus receptorIBA 10/2014 - 11/2003
3	Adenosine Triphosphate (ATP)IBA 10/2009 - 08/2005
2	lazertinibIBA 01/2022 - 12/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 05/2013
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 02/2017
2	CytokinesIBA 01/2021 - 01/2010
2	pembrolizumabIBA 01/2019 - 04/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 12/2016
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 01/2015
2	nimotuzumabIBA 08/2017 - 02/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 08/2010
2	Alanine Transaminase (SGPT)IBA 12/2016 - 04/2016
2	Everolimus FDA Link 03/2016 - 01/2016
2	Sorafenib (BAY 43-9006)FDA Link 03/2016 - 01/2016
2	NucleotidesIBA 03/2016 - 02/2007
2	SmokeIBA 04/2011 - 01/2010
2	Phosphotransferases (Kinase)IBA 12/2009 - 02/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2008 - 02/2007
2	Estrogen Receptor betaIBA 05/2006 - 07/2003
1	AntibodiesIBA 07/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	belotecanIBA 01/2021
1	CamptothecinIBA 01/2021
1	InterleukinsIBA 01/2021
1	tremelimumabIBA 12/2020
1	LigandsIBA 01/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2018
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2018
1	roniciclibIBA 01/2018

Therapy/Procedure

28	Therapeutics 01/2022 - 11/2002
25	Drug Therapy (Chemotherapy) 12/2020 - 08/2005
3	Aftercare (After-Treatment) 07/2021 - 07/2014
3	Chemoradiotherapy 08/2015 - 02/2010
2	Immunotherapy 01/2020 - 01/2018
2	Molecular Targeted Therapy 01/2019 - 04/2011
2	Radiotherapy 02/2010 - 05/2007
1	Precision Medicine 01/2019